Zebra Capital Management LLC Harrow Health, Inc. Transaction History

Zebra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $112,321 - $143,678	-16,591 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $6,842 - $9,660	805 Added 5.1%	16,591 $143,000
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $3,373 - $5,590	505 Added 3.3%	15,786 $147,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $267,809 - $471,874	-42,781 Reduced 73.68%	15,281 $103,000
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $28,141 - $40,970	5,912 Added 11.34%	58,062 $398,000
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $245,626 - $383,824	52,150 New	52,150 $291,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.